Related Experiment Videos
Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer
D Campani1, R Sarnelli, G Fontanini
1Institute of Pathological Anatomy, Medical School, University of Pisa, Italy.
Annals of the New York Academy of Sciences
|November 30, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Detection of acidic paper recovery after alkaline nanoparticle treatment by 2D NMR relaxometry.
Magnetic resonance in chemistry : MRC·2020
Ocular surface involvement in patients with neurofibromatosis type 1 syndrome.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2020
A Two-Stage Grip Force Estimation Method for Surgical Robots Based on BiLSTM-iTransformer.
Annals of the New York Academy of Sciences·2026
Digital Balance Biomarkers and Interpretable Evaluation of Disease Severity in Spinocerebellar Ataxia Type 3.
Annals of the New York Academy of Sciences·2026
Individual and Contextual Socioeconomic Position on Type 2 Diabetes Risk in LMICs: A Multilevel Analysis.
Annals of the New York Academy of Sciences·2026
Critical Review on the Development and Evolution of Beat Perception.
Annals of the New York Academy of Sciences·2026
PIEZO1 Mediates Myoblast Proliferation Under Simulated Microgravity.
Annals of the New York Academy of Sciences·2026
HMM-PMM: A Parallel Hidden Markov Model-Based Map-Matching Framework for Large-Scale Trajectory Data.
Annals of the New York Academy of Sciences·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026